Restart Life Sciences Corp. (CSE: HEAL)
Canada
· Delayed Price · Currency is CAD 0.0900
0.00 (0.00%)
Jan 31, 2025, 4:00 PM EST
Restart Life Sciences Income Statement
Financials in millions CAD. Fiscal year is January - December.
Millions CAD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Revenue | -0.03 | - | - | - | 0.01 | 0.01 | Upgrade
|
| Revenue Growth (YoY) | - | - | - | - | 59.51% | - | Upgrade
|
| Cost of Revenue | - | - | - | 0.01 | 0.01 | 0.01 | Upgrade
|
| Gross Profit | -0.03 | - | - | -0.01 | 0 | 0 | Upgrade
|
| Selling, General & Admin | 0.53 | 0.86 | 1.4 | 1.58 | 0.63 | 0.82 | Upgrade
|
| Research & Development | 0 | 0.07 | 0.12 | 0.86 | 0.05 | - | Upgrade
|
| Operating Expenses | 0.53 | 1.21 | 1.85 | 2.8 | 1.58 | 1.1 | Upgrade
|
| Operating Income | -0.56 | -1.21 | -1.85 | -2.8 | -1.58 | -1.1 | Upgrade
|
| Interest & Investment Income | 0 | 0 | 0 | 0 | 0 | 0.02 | Upgrade
|
| Earnings From Equity Investments | - | - | - | - | - | -0.09 | Upgrade
|
| Other Non Operating Income (Expenses) | -0.01 | -0.02 | 0.14 | -0.04 | -0.22 | -0.13 | Upgrade
|
| EBT Excluding Unusual Items | -0.56 | -1.22 | -1.71 | -2.84 | -1.8 | -1.3 | Upgrade
|
| Gain (Loss) on Sale of Investments | -0.01 | - | - | 0.02 | -5.69 | -0.03 | Upgrade
|
| Gain (Loss) on Sale of Assets | 0.58 | - | - | - | - | - | Upgrade
|
| Other Unusual Items | - | - | -0.76 | 0.13 | -17.74 | -0.08 | Upgrade
|
| Pretax Income | 0.02 | -1.22 | -2.47 | -2.68 | -25.23 | -1.4 | Upgrade
|
| Net Income | 0.02 | -1.22 | -2.47 | -2.68 | -25.23 | -1.4 | Upgrade
|
| Net Income to Common | 0.02 | -1.22 | -2.47 | -2.68 | -25.23 | -1.4 | Upgrade
|
| Shares Outstanding (Basic) | 15 | 15 | 14 | 11 | 5 | 3 | Upgrade
|
| Shares Outstanding (Diluted) | 15 | 15 | 14 | 11 | 5 | 3 | Upgrade
|
| Shares Change (YoY) | 4.10% | 7.47% | 22.92% | 117.20% | 59.88% | 8.12% | Upgrade
|
| EPS (Basic) | 0.00 | -0.08 | -0.18 | -0.24 | -4.93 | -0.44 | Upgrade
|
| EPS (Diluted) | -0.00 | -0.08 | -0.18 | -0.24 | -4.93 | -0.44 | Upgrade
|
| Free Cash Flow | -0.08 | -0.28 | -2.41 | -1.95 | -0.86 | -0.88 | Upgrade
|
| Free Cash Flow Per Share | -0.01 | -0.02 | -0.18 | -0.18 | -0.17 | -0.27 | Upgrade
|
| Gross Margin | - | - | - | - | 15.07% | 22.61% | Upgrade
|
| Operating Margin | - | - | - | - | -13782.54% | -15238.64% | Upgrade
|
| Profit Margin | - | - | - | - | -219950.23% | -19439.47% | Upgrade
|
| Free Cash Flow Margin | - | - | - | - | -7466.27% | -12219.29% | Upgrade
|
| EBITDA | -0.56 | -1.2 | -1.84 | -2.8 | -1.57 | -1.09 | Upgrade
|
| D&A For EBITDA | 0 | 0 | 0 | 0 | 0.01 | 0.01 | Upgrade
|
| EBIT | -0.56 | -1.21 | -1.85 | -2.8 | -1.58 | -1.1 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.